Sunday, August 10, 2025

Medipharm Labs Expands Facility Threefold, Introduces New Automated Processes

Medipharm Labs (TSX: LABS) has received Health Canada licensing for its newly expanded production facility in Barrie, Ontario. The expanded space will see the effective size of Medipharm’s licensed area increase significantly to approximately 25,000 square feet, from that of roughly 8,200 square feet.

The expanded space will largely be utilized for its white label operations. The space will be used in Medipharm’s current manufacturing operation to enable the firm to be able to introduce automated downstream production and packaging, expand upon current quality control and testing, as well as provide additional space for research and development as well as product storage.

While not currently licensed under GMP standards like the current operation, the expanded space has been built to compliance and is expected to receive approval for expanded GMP operations. Thus, the expansion will also enable the extractor to provide enhanced international medical products for the European marketplace. In terms of specific products, the firm has identified that it intends to move vape pen production into the newly expanded space upon GMP approval for international distribution.

The recently received approval completes Medipharm’s first phase of facility expansion at its Barrie, Ontario facility. The phase included five new manufacturing rooms, an expanded quality control lab, a second storage location, as well as infrastructure upgrades. Recently received automation equipment is expected to be operational in the coming weeks, enabling the firm to offer enhanced white label production for its partners.

Medipharm Labs last traded at $3.93 on the TSX.


Information for this briefing was found via Sedar and Medipharm Labs.. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Queensway PEA

Newmont Q2 Earnings: Setting The Tone For This Earnings Cycle

Highest Grade Antimony Mine in the World!? | James Atkinson – Antimony Resources

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Medipharm Labs Reports Q4 Revenues Of $6.1 Million, Net Loss Of $30.9 Million

Medipharm Labs (TSX: LABS) this morning reported its fourth quarter financial results for 2020. Revenues...

Wednesday, March 31, 2021, 07:47:27 AM

Medipharm Labs Settles $41.0 Million Debt After Blowing Out Share Structure

Medipharm Labs (TSX: LABS) appears to be focused on cleaning up its balance sheet. The...

Wednesday, January 5, 2022, 08:04:55 AM

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues To Post Negative Gross Margins

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of...

Monday, November 15, 2021, 08:54:23 AM

Rough Week In Cannabis Sector Capped With Gut Punch From Ontario

This first week of April has been the never-ending week for the cannabis industry that...

Friday, April 3, 2020, 03:24:27 PM